Analysts See $0.03 EPS for Luminex (LMNX); Bunge LTD (BG) Sentiment Is 0.8

October 12, 2017 - By reb123z

Analysts expect Luminex Corporation (NASDAQ:LMNX) to report $0.03 EPS on October, 30.They anticipate $0.03 EPS change or 50.00% from last quarter’s $0.06 EPS. LMNX’s profit would be $1.32M giving it 172.50 P/E if the $0.03 EPS is correct. After having $0.20 EPS previously, Luminex Corporation’s analysts see -85.00% EPS growth. About 51,358 shares traded. Luminex Corporation (NASDAQ:LMNX) has risen 6.31% since October 12, 2016 and is uptrending. It has underperformed by 10.39% the S&P500.

Bunge Limited is an agribusiness and food firm with integrated activities that stretch from the farm field to consumer foods. The company has market cap of $9.47 billion. The Firm operates through five divisions: Agribusiness, Edible Oil Products, Milling Products, Sugar and Bioenergy, and Fertilizer. It has a 19.46 P/E ratio. The Company’s Agribusiness segment is an integrated, global business involved in the purchase, storage, transport, processing and sale of agricultural commodities and commodity products.

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The company has market cap of $912.27 million. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease divisions. It has a 63.09 P/E ratio. The Firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.

Among 7 analysts covering Luminex Corp (NASDAQ:LMNX), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Luminex Corp had 11 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was upgraded by JP Morgan on Thursday, August 18 to “Neutral”. The stock has “Mkt Outperform” rating by Avondale on Wednesday, October 12. The rating was maintained by Jefferies on Friday, June 9 with “Hold”. The firm has “Outperform” rating by Wedbush given on Tuesday, August 4. Piper Jaffray maintained it with “Hold” rating and $19.0 target in Sunday, September 17 report. As per Wednesday, August 5, the company rating was maintained by Jefferies. Jefferies maintained Luminex Corporation (NASDAQ:LMNX) rating on Wednesday, September 13. Jefferies has “Hold” rating and $21.0 target.

Analysts await Bunge Ltd (NYSE:BG) to report earnings on November, 1. They expect $1.22 earnings per share, up 67.12% or $0.49 from last year’s $0.73 per share. BG’s profit will be $171.31M for 13.82 P/E if the $1.22 EPS becomes a reality. After $0.17 actual earnings per share reported by Bunge Ltd for the previous quarter, Wall Street now forecasts 617.65% EPS growth.

About 262,590 shares traded. Bunge Ltd (BG) has risen 14.04% since October 12, 2016 and is uptrending. It has underperformed by 2.66% the S&P500.

Boussard & Gavaudan Investment Management Llp holds 6.23% of its portfolio in Bunge Ltd for 1.18 million shares. Managed Asset Portfolios Llc owns 176,617 shares or 4.35% of their US portfolio. Moreover, Lesa Sroufe & Co has 4.12% invested in the company for 59,602 shares. The New York-based York Capital Management Global Advisors Llc has invested 2.86% in the stock. Carlson Capital L P, a Texas-based fund reported 2.41 million shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: